Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Wake Forest University Health Sciences
Filamon LTD
Varian, a Siemens Healthineers Company
Novartis
Fondazione del Piemonte per l'Oncologia
PMV Pharmaceuticals, Inc
Pfizer
AstraZeneca
Novartis
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Region Jönköping County
Fred Hutchinson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
Eli Lilly and Company
UMC Utrecht
AstraZeneca
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Aveni Foundation
University of Chicago
Bayer
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
ViroMissile, Inc.
EMD Serono
University of California, Davis
Replimune Inc.
Terremoto Biosciences Inc.
Gustave Roussy, Cancer Campus, Grand Paris